Background Postoperative nausea and vomiting (PONV) is a common adverse effect of
anaesthesia and surgery. Up to 80% of patients may be affected. These outcomes are a …

Background. In order to identify patients who would benefit from prophylactic amtiemetics,
six predictive models have been described for the risk assessment of postoperative nausea …

Background Untreated, one third of patients who undergo surgery will have postoperative
nausea and vomiting. Although many trials have been conducted, the relative benefits of …

Approximately 1 in 4 patients suffers from postoperative nausea and vomiting. It is fortunate
that risk scores have been developed to help manage this outcome in hospitalized patients …

Background The German-language recommendations for the management of postoperative
nausea and vomiting (PONV) have been revised by an expert committee. Major aspects of …

The incidence of postoperative nausea and vomiting (PONV) after a standard anaesthetic
technique consisting of inhalational anaesthetics and opioids and no PONV prophylaxis is …

Even nowadays every third or fourth patient suffers from postoperative nausea and vomiting
(PONV) after general anaesthesia with volatile anaesthetics. There is now strong evidence …

Background The neurokinin1 antagonist aprepitant is effective for prevention of
chemotherapy-induced nausea and vomiting. We compared aprepitant with ondansetron for …

New antiemetic drug developments, formulations, guidelines, risk evaluation, and
controversies have occurred in the area of postoperative nausea and vomiting (PONV) …

Background Postoperative nausea and vomiting (PONV) is common and of concern to
patients and clinicians. The effect of PONV can range from trivial and transient to major …